Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

HF 3950

as introduced - 90th Legislature (2017 - 2018) Posted on 03/19/2018 03:00pm

KEY: stricken = removed, old language.
underscored = added, new language.

Bill Text Versions

Engrossments
Introduction Posted on 03/19/2018

Current Version - as introduced

Line numbers 1.1 1.2 1.3 1.4 1.5
1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19 2.20 2.21 2.22

A bill for an act
relating to health; requiring an informed consent form to prescribe psychotropic
medications; amending Minnesota Statutes 2016, section 152.12, by adding a
subdivision.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

Minnesota Statutes 2016, section 152.12, is amended by adding a subdivision
to read:


new text begin Subd. 6. new text end

new text begin Informed consent; psychotropic medications. new text end

new text begin (a) The Board of Pharmacy
shall develop an informed consent form for each commonly prescribed psychotropic
medication, to be used by a health care provider authorized to prescribe a controlled substance
under subdivision 1 or the provider's designee. The consent form for each medication must
include the following information or fields, and shall be updated as needed, but must be
updated at least every two years:
new text end

new text begin (1) the patient's name and contact information;
new text end

new text begin (2) the category of the medication;
new text end

new text begin (3) the name of the medication;
new text end

new text begin (4) the daily total dosage range recommended by the Food and Drug Administration,
the Physician's Desk Reference, or another standard reference used by the Board of
Pharmacy;
new text end

new text begin (5) the anticipated dosage range for the individual patient;
new text end

new text begin (6) the method of medication administration;
new text end

new text begin (7) the reason or reasons for the use of the medication, and the benefits expected from
the medication;
new text end

new text begin (8) any alternative methods of treatment other than or in addition to the medication;
new text end

new text begin (9) the probable consequences if the patient refuses the medication;
new text end

new text begin (10) all possible side effects of the medication, categorized as most common, less
common, and rare;
new text end

new text begin (11) all additional necessary warnings relating to the medication's interaction with other
medications, potential for dependence, and other safety concerns; and
new text end

new text begin (12) a list of the patient's rights under section 144.651 relating to medication consent.
new text end

new text begin (b) A health care provider who is authorized to prescribe a controlled substance under
subdivision 1, or the provider's designee, shall provide a patient with the informed consent
form developed by the Board of Pharmacy under paragraph (a) when prescribing a
psychotropic medication for the patient. The patient or the patient's guardian and the health
care provider or the provider's designee must sign the informed consent form for each
psychotropic medication before the medication may be prescribed.
new text end

new text begin (c) For purposes of this subdivision, "psychotropic medication" means any medication
prescribed to treat the symptoms of mental illness that affect thought processes, mood, sleep,
or behavior. The major classes of psychotropic medication are antipsychotic (neuroleptic),
antidepressant, antianxiety, mood stabilizers, anticonvulsants, and stimulants and
nonstimulants for the treatment of attention deficit/hyperactivity disorder. Other
miscellaneous medications are considered to be a psychotropic medication when they are
specifically prescribed to treat a mental illness or to control or alter behavior.
new text end